MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1183/09031936.05.00080804

Медицинская библиотека · The European respiratory journal · 2005

Bosentan therapy for portopulmonary hypertension.

Hoeper M M, Halank M, Marx C, Hoeffken G, Seyfarth H J, Schauer J, Niedermeyer J, Winkler J

СтатьяПеревод в очереди

Аннотация

The dual endothelin receptor antagonist bosentan has been approved in several countries for pulmonary arterial hypertension, and patients with portopulmonary hypertension (PPHTN) have not specifically been excluded. However, no data have been published on the efficacy and safety of bosentan in this patient population. Here, the first clinical experiences with bosentan in patients with Child A cirrhosis and severe PPHTN are reported. In total, 11 consecutive patients with cirrhosis and severe PPHTN in New York Heart Association Functional Classes III and IV were treated for >1 yr with bosentan. After 1 yr of treatment with bosentan, all patients showed improved symptoms and exercise capacity. The 6-min walking distance increased from 310+/-102 m at baseline to 388+/-81 m at 1 yr. Cardiopulmonary exercise testing disclosed a significant increase in peak oxygen uptake, from 12.6+/-3.5 to 16.6+/-2.8 mL.min(-1).kg(-1). Pulmonary vascular resistance fell from 944+/-519 to 635+/-321 dynes.s.L(-1). The medication was well tolerated by all patients, and there was no evidence of drug-related liver injury. In conclusion, bosentan proved to be efficacious and safe in a small number of patients with portopulmonary hypertension.

Для цитирования: Hoeper M M, Halank M, Marx C, Hoeffken G, Seyfarth H J, Schauer J, Niedermeyer J, Winkler J. Bosentan therapy for portopulmonary hypertension.. The European respiratory journal. 2005. DOI: 10.1183/09031936.05.00080804.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.